
Keywords: SDF-1; stromal cell-derived factor 1; PAD; peripheral arterial disease; GPx; glutathione peroxidase; TAK1; transforming growth factor-B-activated-kinase 1; PTP1B; protein tyrosine phosphatase 1B; EDRF; endothelial-derived relaxing factor (EDRF); BH4; tetr